Genmab — Juli 2023
-
Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY
) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) https://ir.genmab.com/news-releases/news-release-details/genmab-announces-abbvie-receives-positive-chmp-opinion -
Har administrator slettet i dagens chat?
-
Næ..Hvorfor det?
-
Syns blot jeg læste to indlæg om udtalelse fra CHMP, men jeg skal måske forbi Louis Nielsen. Tak
-
Ok. Det var mit eget som var magen til det fra E L . Derfor blev det slettet.
-
Vi postede i samme sekund. Opdagede først fejlen lidt senere.
-
Det kan næppe være en fejl
-
Janssen Receives Positive CHMP Opinions for Novel Bispecific Antibodies TALVEY
▼ (talquetamab) and TECVAYLI▼ https://www.jnj.com/janssen-receives-positive-chmp-opinions-for-novel-bispecific-antibodies-talvey-talquetamab-and-tecvayli-teclistamab-for-the-treatment-of-patients-with-relapsed-and-refractory-multiple-myeloma -
-
S&P500 healthcare er steget pænt siden 7/7. https://www.spglobal.com/spdji/en/indices/equity/sp-500-health-care-sector/
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind